References
- Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101(3):791–800.
- Yin XL, Wu ZK, Zhou XY, et al. Co-inherited β-thalassemia trait and Hb H disease: clinical characteristics and interference in diagnosis of thalassemia by high-performance liquid chromatography. Int J Lab Hematol. 2012;34(4):427–431.
- Zarei T, Dehbozorgian J, Imanifard J, et al. A number of cases in Iran presenting with coinheritance of Hemoglobin-H disease and beta-thalassemia minor. Hemoglobin. 2016;40(5):316–318.
- Liao C, Li Q, Wei J, et al. Prenatal control of Hb Bart’s disease in southern China. Hemoglobin. 2007;31(4):471–475.
- Li J, Li R, Li DZ. Identification of nondeletional α-thalassemia in a prenatal screening program by reverse dot-blot in southern China. Hemoglobin. 2015;39(1):42–45.
- Li D, Liao C, Li J, et al. Prenatal diagnosis of β-thalassemia by reverse dot-blot hybridization in southern China. Hemoglobin. 2006;30(3):365–708.
- Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of Hemoglobin H disease in Chinese patients. N Engl J Med. 2000;343(8):544–550.
- Waye JS, Eng B, Patterson M, et al. Hemoglobin H (Hb H) disease in Canada: molecular diagnosis and review of 116 cases. Am J Hematol. 2001;68(1):11–15.
- Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069 (http://globin.cse.psu.edu).
- Baysal E, Kleanthous M, Bozkurt G, et al. α-Thalassaemia in the population of Cyprus. Br J Haematol. 1995;89(3):496–499.
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Yin A, Li B, Luo M, et al. The prevalence and molecular spectrum of α- and β-globin gene mutations in 14,332 families of Guangdong Province, China. PLoS One. 2014;9(2):e89855.
- Bowden DK, Hill AV, Higgs DR, et al. Different hematologic phenotypes are associated with the leftward (–α4.2) and rightward (–α3.7) α+-thalassemia deletions. J Clin Invest. 1987;79(1):39–43.
- Old J, Harteveld CL, Traeger-Synodinos J, et al. Prevention of Thalassaemias and Other Haemoglobin Disorders: Laboratory Protocols, 2nd ed [Internet]. Nicosia (Cyprus): Thalassaemia International Federation, 2012.
- Amirian A, Jafarinejad M, Kordafshari AR, et al. Identification of a novel δ-globin gene mutation in an Iranian family. Hemoglobin. 2010;34(6):594–598.
- Morgado A, Picanço I, Gomes S, et al. Mutational spectrum of δ-globin gene in the Portuguese population. Eur J Haematol. 2007;79(5):422–428.
- Colaco S, Trivedi A, Colah RB, et al. Masking of a β-thalassemia determinant by a novel δ-globin gene defect [Hb A2-Saurashtra or δ100(G2)Pro→Ser; HBD: c.301C>T] in cis. Hemoglobin. 2014;38(1):24–27.